C‐abl and bcr are rearranged in a Ph1‐negative CML patient.

Authors:
  • CBC.R. Bartram
    C.R. Bartram
  • EKE. Kleihauer
    E. Kleihauer
  • AKA. de Klein
    A. de Klein
  • GGG. Grosveld
    G. Grosveld
  • JTJ.R. Teyssier
    J.R. Teyssier
  • NHN. Heisterkamp
    N. Heisterkamp
  • JGJ. Groffen
    J. Groffen

Abstract
Chromosomal analysis of a patient with chronic myelocytic leukemia (CML) revealed a translocation (9;12) (q34;q21) without a detectable Philadelphia chromosome (Ph1). Using molecular approaches we demonstrate (i) a rearrangement within the CML breakpoint cluster region (bcr) on chromosome 22, and (ii) a joint translocation of bcr and c‐abl oncogene sequences to the derivative chromosome 12. These observations support the view that sequences residing on both chromosome 9 (c‐abl) and 22 (bcr) are involved in the generation of CML and suggest that a subset of Ph1‐negative patients may in fact belong to the clinical entity of Ph1‐positive CML.

This publication has 23 references indexed in Scilit: